Please check your internet connection and try again.
# Tus%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd
## Overview
Tus%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd is a combination medication containing dextromethorphan (a cough suppressant) and guaifenesin (an expectorant).
## Primary Indications
* Symptomatic relief of cough and chest congestion associated with the common cold, bronchitis, or other respiratory conditions.
## Adult Dosing
* **Dextromethorphan/Guaifenesin:** Typically 10-20 mg / 200-400 mg orally every 4-12 hours as needed.
* Maximum daily dose of dextromethorphan is generally 120 mg. Specific maximums for combination products vary. Always refer to product labeling.
## Pediatric Dosing
* **Dextromethorphan/Guaifenesin:** Dosing varies by age and product formulation.
* Generally, for children 6-12 years: 5-10 mg dextromethorphan / 100-200 mg guaifenesin every 4-12 hours.
* **Not recommended for children under 6 years of age** unless specifically directed by a healthcare provider, due to increased risk of adverse effects.
## Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment. However, caution and close monitoring may be warranted in severe impairment.
## Contraindications
* Hypersensitivity to dextromethorphan or guaifenesin.
* Use within 14 days of MAO inhibitor therapy.
* Patients with respiratory depression, severe hepatic impairment, or uncontrolled asthma.
## Adverse Effects
* **Common:** Dizziness, drowsiness, nausea, vomiting, stomach upset.
* **Less Common/Serious:** Confusion, hallucinations, respiratory depression (especially with overdose), serotonin syndrome (with concomitant serotonergic agents).
## Key Drug Interactions
* **MAO Inhibitors:** Increased risk of hypertensive crisis and serotonin syndrome.
* **Serotonergic Agents (e.g., SSRIs, SNRIs, triptans):** Increased risk of serotonin syndrome.
* **CNS Depressants (e.g., alcohol, benzodiazepines, opioids):** Additive sedative effects.
* **CYP2D6 Inhibitors (e.g., fluoxetine, paroxetine, quinidine):** May increase dextromethorphan levels, potentially leading to toxicity.
## Monitoring
* Assess for effectiveness in reducing cough and congestion.
* Monitor for signs of sedation, dizziness, and central nervous system effects.
* Observe for signs of serotonin syndrome, especially if taking other serotonergic medications.
## Clinical Pearls
* Dextromethorphan can be abused for its psychoactive effects; counsel patients on appropriate use.
* Ensure adequate hydration to help guaifenesin thin mucus.
* The combination formulation aims to suppress cough while also loosening mucus, but individual responses may vary.
***
***Disclaimer:** This information is intended for healthcare professionals. Please consult the official prescribing information and relevant clinical guidelines for the most up-to-date and comprehensive details before making any treatment decisions. This response does not constitute medical advice.*